🔴 Standard Biotools is trading 5.6% down

Standard Biotools is trading 5.6% lower at $0.72, with no clear company-specific catalyst identified.

• The price is down from the October 5 close of $0.76; the broader market is higher, so its move does not explain the decline.
• On October 5, the company announced an agreement to sell its Microfluidics business to ARCHIMED, with closing expected in approximately 30 days. Available reporting does not establish that the announcement caused the October 6 decline.